Tirzepatide: tested in a combination
36 studies: another drug in the study is under test too. Page 1 of 1. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.
- Mechanisms of Weight Loss: Tirzepatide vs SemaglutideRecruitingNCT07900074Phase 4Report a problem
- Dietary, Medication, and Endoscopic Interventions for Post-Bariatric HypoglycemiaNot yet recruitingNCT07878494Not applicableReport a problem
- Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1sNot yet recruitingNCT07832084Phase 4Report a problem
- Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo TransferNot yet recruitingNCT07811895Not applicableReport a problem
- Tirzepatide Impact Assessment StudyRecruitingNCT07740291Not applicableReport a problem
- Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA TrialNot yet recruitingNCT07676331Phase 2Report a problem
- New Triple Combination Therapy in Newly Diagnosed Type 2 DiabetesNot yet recruitingNCT07635953Phase 3Report a problem
- GLP-1 Therapy After Bariatric Surgery in Chinese Patients With ObesityRecruitingNCT07633639Not applicableReport a problem
- Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTsRecruitingNCT07589322Not applicableReport a problem
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot StudiesNot yet recruitingNCT07483801Phase 4Report a problem
- Combination of Biologic and Anti-obesity Therapies in Psoriatic ArthritisRecruitingNCT07443956Not applicableReport a problem
- Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart DiseaseNot yet recruitingNCT07354880Phase 4Report a problem
- A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or ObeseRecruitingNCT07326111Phase 4Report a problem
- Effect of Semaglutide and Tirzepatide Combined With Exercise in ObesityNot yet recruitingNCT07319975Not applicableReport a problem
- Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With ObesityRecruitingNCT07293325Not applicableReport a problem
- Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT TrialRecruitingNCT07202247Phase 2Report a problem
- Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm HealthNot yet recruitingNCT07179120Phase 2Report a problem
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)RecruitingNCT07165028Phase 3Report a problem
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial NeoplasiaRecruitingNCT07107334Phase 2Report a problem
- Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal WomenEnrolling by invitationNCT07057310Phase 4Report a problem
- Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or TirzepatideRecruitingNCT06657209Phase 4Report a problem
- Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in AdolescentsRecruitingNCT06575738Phase 1Report a problem
- Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset DiabetesRecruitingNCT06246799Phase 3Report a problem
- Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 YearsRecruitingNCT05990374Not applicableReport a problem
- Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With ObesityRecruitingNCT05933499Phase 2Report a problem
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 AnalogueRecruitingNCT05751720Phase 1/2Report a problem
- Holding vs. Continuing Incretin-based Therapies Before Upper EndoscopyCompletedNCT06533527Phase 4Results postedReport a problem
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothCompletedNCT05260021Phase 3Results postedReport a problem
- Weekly GLP-1 Receptor Agonists in Obese Individuals Without DiabetesCompletedNCT07834398Phase 3Report a problem
- Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical TrialCompletedNCT07820111Phase 3Report a problem
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 DiabetesWithdrawnNCT06901349Phase 2Report a problem
- Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)Active, not recruitingNCT06854614Phase 4Report a problem
- Bariatric Surgery vs. Semaglutide vs. TirzepatideActive, not recruitingNCT06803888Phase 4Report a problem
- Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor FunctionsActive, not recruitingNCT06801015Phase 4Report a problem
- Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic ParticipantsCompletedNCT06648031Phase 1Report a problem
- A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or OverweightCompletedNCT06643728Phase 2Report a problem